|
|
OJHAS: Vol. 2, Issue
2: (2003 Apr-Jun) |
|
|
A Survey on Ophthalmia Neonatorum in Benin
City, Nigeria (Emphasis on gonococcal ophthalmia) |
|
|
Eghosasere Iyamu, Onaiwu
Enabulele Department of Optometry, and Department of Microbiology, University of Benin, Benin City,
Nigeria. |
|
|
|
|
|
Address For Correspondence |
|
Eghosasere
Iyamu,
Department of Optometry, University of Benin, Benin City, Nigeria
E-mail: eghosaiyamu@yahoo.com
|
|
|
Iyamu E,
Enabulele O. A Survey on Ophthalmia Neonatorum in Benin City, Nigeria (Emphasis on
gonococcal ophthalmia).
Online J Health Allied Scs.2003;2:2 |
|
Submitted: Apr 7,
2003; revised: Jul 23, 2003; Accepted: Aug 10, 2003; Published: Aug
14, 2003 |
|
|
|
|
|
|
|
|
Abstract: |
The purpose of the study was
to investigate the incidence of gonococcal ophthalmia neonatorum considering its ability
to lead to childhood blindness through corneal ulceration and scarification. Eye swabs
were obtained from 330 neonates of 1-5 days in the hospitals of study. Of these, 248
yielded growth and six bacterial genera were identified using standard techniques. Staphylococcus
aureus was the most prevalent (60.5%) while Neisseria gonorrhoeae accounted for
1.7%. Susceptibility patterns of bacterial isolates to four antibiotics were determined
using Disk-diffusion tests. Staphylococcus aureus and Neisseria gonorrhoeae
showed 62.5 and 100% susceptibility to Erythromycin while 66.7% of Escherichia coli and
Klebsiella and 62.5% of Pseudomonas aeruginosa were susceptible to Gentamicin.
The incidence of gonococcal ophthalmia neonatorum for the period of study was 8.9 (cases
per 1,000 live births). Prevention is through ocular prophylaxis by the application of
either 1% silver nitrate ophthalmic solution or 0.5% erythromycin ointment to the
neonates eyes some hours after birth. This would help to preserve vision and reduce
to the barest minimum the incidence of childhood blindness.
Key Words:
Ophthalmia
neonatorum, gonococcus, ocular prophylaxis, childhood blindness |
|
Ophthalmia neonatorum (neonatal
conjunctivitis) is defined as a conjunctival inflammation that occurs during the first
month of life.(1,2) It presents with acute purulent (pus) discharge from the eyes, usually
bilateral and associated with chemosis (edema of the conjunctiva), marked hyperemia and
lid edema, which if left untreated can lead to blindness through corneal ulceration and
scarification.(3,4)
The neonates conjunctiva is sterile
at birth but soon becomes colonized by various microorganisms that may either be
pathogenic or non-pathogenic. The neonates conjunctiva is prone to infection, not
only because there are low levels of antibacterial agents and proteins like lysozyme and
immunoglobulin A and G, but because the tear film and flow are only just beginning to
develop.(5,6)
In Canada, 71 cases of gonococcal
ophthalmia neonatorum were reported within 1989-1998.(7) For Florida in United States of
America, 68 cases of gonococcal infections were identified between 1984 and 1988. The rate
of clinical gonococcal ophthalmia neonatorum in Florida hospitals from which cases had
been reported was 1.7 per 10,000 live births.(8) In another study carried out in Aires,
Argentina over a period of four years, neonatal conjunctivitis had an incidence (cases per
10,000 live births) of 39.6 in 1995, 25.3 in 1996, 15.5 in 1997 and 15.2 in 1998.(9)
Ophthalmia neonatorum still leads to
blindness in approximately 10,000 babies annually worldwide.(10) In the study carried out
in Kenya, four perinatal factors namely maternal vaginitis, presence of meconium at birth,
birth in a non-sterile environment and postnatal development of endometritis were
identified.(10) In another study, premature rupture of membranes, documented or suspected
sexually transmitted disease and local eye injury during delivery were identified as risk
factors for ophthalmia neonatorum to occur.(11)
Most ophthalmic infections in the
neonatal period are acquired during vaginal delivery and reflect the sexually transmitted
diseases prevalent in the community.(2) The transmission rate of gonorrhoea from an
infected mother to her newborn is 30 50%.(2,12,13) Vertical transmission may play
an important role in neonatal conjunctivitis, as 67% of bacteria from the infected
neonates were similar to those detected in lower genital tract and placentae of mothers,
as shown in the study conducted in Beijing by Gao.(14)
Numerous studies have shown that Chlamydia
trachomatis, Staphylococcus aureus, Neisseria gonorrhoeae, Streptococcus
pneumoniae, Haemophilus influenzae, Escherichia coli, Klebsiella sp,
Pseudomonas aeruginosa as well as chemical agents have been identified as causative
agents of ophthalmia neonatorum.(11,15,17) The most important bacterium by its potential
to damage vision was Neisseria gonorrhoeae.(11) Staphylococcus aureus, Pseudomonas
aeruginosa, Chlamydia trachomatis have at one point or the other been
identified as the commonest causative agents.(17-21)
Neisseria gonorrhoeae has a strong
affinity for columnar and transitional epithelium and having attached to the mucosal cells
begins to produce substances like proteases, elastases that play an important role in its
pathogenicity. The end result is the development of ophthalmia neonatorum when the neonate
is delivered through the passage where the organism is already established.(7,15)
Corneal ulceration, perforation,
scarification and consequent blindness result from untreated or poorly treated gonococcal
ophthalmia neonatorum.(2,12,13,22)
Clinical presentations of ophthalmia
neonatorum are not diagnostic of the cause, and microbiologic work-up with cytology,
cultures and microbial sensitivities is mandatory. The selection of specific antimicrobial
therapy is based on the findings of laboratory.(23)
A single low dose of ceftriaxone (62.5mg
for babies and 125mg for mothers) has been shown to eradicate Neisseria gonorrhoeae
from all babies eyes with no residual damage, as well as from the mothers
cervices.(24) Cefixime, ceftriaxone, third generation cephalosporins and the
fluoroquinolones are generally effective against Neisseria gonorrhoeae.(7)
The ideal prophylactic agent would be
both non-toxic and highly effective in preventing gonococcal, chlamydial and nongonococcal
and nonchlamydial ophthalmia neonatorum. Since gonococcal ophthalmia poses the greatest
threat to a childs vision, the principal goal of ocular prophylaxis is the
prevention of gonococcal infections.(15) Application of topical 1% silver nitrate to the
eyes of newborns has helped in the prevention of gonorrheal ophthalmia.(25-28)
Erythromycin and tetracycline are other prophylactic agents that can be utilized in
newborns to prevent the disease.(13,27,29,30) All three agents have been found to be
effective against the disease when used separately.(15,27,31) The effectiveness and safety
of povidone-iodine were studied along side with 1% silver nitrate and 0.5% erythromycin,
and was found to be more effective.(10,29,32,33) Management of ophthalmia neonatorum
should be syndromic and systemic. Contact tracing is an integral part of the
management.(34)
Samples were collected by swabbing the
lower conjunctival surfaces (with sterile swabs) of healthy neonates within 1-5 days at
the special baby units of University of Benin Teaching Hospital and Central Hospital in
Benin City, Nigeria. The swabs in the containers were labeled for the required tests and
then transported to the Microbiology laboratories of the hospitals within two hours of
collection. On arrival at the laboratories, the specimens were registered and then
cultured onto pre-labeled oven-dried agar plates (Chocolate, Nutrient and Blood agar) at
37oC for 24 hours. The chocolate plates were incubated under microaerophilic
conditions or anaerobic environment using CO2 jar. After the overnight
incubation, the culture plates with growth were streaked and sub-cultured for another 24
hours at 37oC. The agar plates without growth were further incubated for 24
hours at 37oC after which those with growth were sub-cultured for purification.
Using standard techniques, which included cultural, colonial morphology and biochemical
characteristics of these isolates on the media, identified the isolates obtained. The
antibiotic susceptibility patterns were determined by using Disk-diffusion tests.
A total of 220 eye swabs were collected
from neonates (with and without discharges) in University of Benin Teaching Hospital. 195
samples yielded growth of which 175 were from discharging and 20 from non-discharging
eyes. For Central hospital, a total of 110 eyes swabs were obtained from neonates with and
without discharges. Of this number, 88 yielded growth while 22 yielded no growth; 73 were
from discharging eyes and 15 were from non-discharging eyes. The identification of the
isolates is presented in Table 1. Tables 2 and 3 show the number of isolates obtained from
diseased and healthy eyes of neonates from the hospitals.
Table 1: Identification of bacterial
isolates
+ Positive Test; - Negative Test; A =
Acid production; gas may or may not be produced; NA = No acid production
Morphology |
Gram stain |
Lact-
ose |
Glu-
cose |
Man-
nitol |
Cata-
lase |
Coag-
ulase |
Man-
nose |
Methyl red |
Voges Pros-
kauer |
Motility |
Citrate |
Indole |
Oxid-
ase |
Urease |
Probable identity
of isolates |
Rods in short chains |
- |
A |
A |
A |
+ |
- |
A |
+ |
- |
+ |
- |
+ |
- |
- |
Escherichia coli |
Cocci in pairs |
- |
NA |
A |
NA |
- |
- |
NA |
- |
- |
- |
- |
- |
+ |
- |
Neisseria gonorrhoeae |
Rods in long chains and clusters |
- |
NA |
A |
NA |
+ |
- |
NA |
+ |
+ |
- |
+ |
- |
+ |
+ |
Pseudomonas aeruginosa |
Short rods in pairs |
- |
A |
A |
A |
+ |
- |
NA |
- |
- |
- |
+ |
- |
- |
+ |
Klebsiella
sp |
Cocci in clusters |
+ |
NA |
A |
NA |
+ |
+ |
NA |
- |
- |
- |
- |
- |
- |
- |
Staphylococcus aureus |
Cocci in chains |
+ |
NA |
NA |
NA |
- |
- |
NA |
- |
- |
- |
- |
- |
- |
- |
Streptococcus sp |
Table 2: Number of bacterial isolates
obtained from diseased and healthy eyes (University of Benin Teaching Hospital)
Organisms |
Number of isolates from diseased eyes n=175(%) |
Number of isolates from healthy eyes n=20(%) |
Staphylococcus aureus |
104(59.4) |
11(55) |
Streptococcus viridans |
19(10.9) |
4(20) |
Escherichia coli |
27(15.4) |
3(15) |
Klebsiella sp |
6(3.4) |
2(10) |
Pseudomonas aeruginosa |
16(9.1) |
0 |
Neisseria gonorrhoeae |
3(1.7) |
0 |
Table 3: Number of bacterial isolates
obtained from diseased and healthy eyes (Central Hospital)
Microorganisms |
Number of isolates from diseased eyes. n= 73 (%) |
Number of isolates from healthy eyes. n= 15 (%) |
Staphylococcus
aureus |
46(63) |
7(46.7) |
Streptococcus
sp |
19(26) |
4(26.7) |
Escherichia
coli |
4(5.5) |
3(20) |
Pseudomonas
aeruginosa |
3(4.1) |
1(6.7) |
Neisseria
gonorrhoeae |
1(1.4) |
0 |
The difference between the number of
isolates from diseased and healthy eyes was statistically significant by Wilcoxon (p=0.02)
for samples from University of Benin Teaching Hospital. However, the difference in the
number of isolates from diseased and healthy eyes of neonates from Central Hospital was
not statistically significant (p=0.31). Escherichia coli and Klebsiella sp
showed 66.7% and Pseudomonas aeruginosa 62.5% susceptibility to gentamicin. In
addition, Staphylococcus aureus and Neisseria gonorrhoeae showed 62.5 and
100% susceptibility to erythromycin. From this study, the organisms implicated in
ophthalmia neonatorum in order of decreasing frequency are Staphylococcus aureus, Streptococcus
sp, Escherichia coli, Pseudomonas aeruginosa, Klebsiella sp and
Neisseria gonorrhoeae (Table 4). The incidence of gonococcal ophthalmia neonatorum
for the study period was 8.9 (Table 5).
Table 4: Frequency of organisms
implicated in ophthalmia neonatorum in the hospitals of study.
Organisms |
Total number of isolates from diseased eyes n=248 |
% |
Staphylococcus
aureus |
150 |
60.5 |
Streptococcus
sp |
38 |
15.3 |
Escherichia
coli |
31 |
12.5 |
Pseudomonas
aeruginosa |
19 |
7.7 |
Klebsiella
sp |
6 |
2.4 |
Neisseria
gonorrhoeae |
4 |
1.6 |
Table 5: Incidence of gonococcal ophthalmia
neonatorum in the hospitals of study for January December, 2001
Hospitals |
Total number of bacterial isolates from diseased eyes |
Total number of Neisseria gonorrhoeae |
Incidence of gonococcal ophthalmia neonatorum (per 1,000 live births) |
Total live births |
University
of Benin Teaching Hospital |
175 |
3 |
10.6 |
283 |
Central
Hospital |
73 |
1 |
5.9 |
169 |
University
of Benin Teaching hospital and Central hospital |
248 |
4 |
8.9 |
452 |
This study shows that
several organisms were isolated from the eye swabs of neonates with conjunctivitis. These
same organisms have been isolated in previous studies.(11,15,17) Staphylococcus aureus
predominated as a cause of ophthalmia neonatorum. Streptococcus sp, Escherichia
coli, Pseudomonas aeruginosa, Klebsiella sp and Neisseria gonorrhoeae
followed this. Chlamydia trachomatis was not isolated. This finding is consistent
with the results of other investigators (17,18) who reported that Staphylococcus aureus
was the commonest causative agent of ophthalmia neonatorum in their studies. In one of
these studies, Staphylococcus aureus was followed by Escherichia coli, Pseudomonas
aeruginosa, while Chlamydia trachomatis and Neisseria gonorrhoeae were
responsible for less than 5% of all cases. This study however differed from that of Yetman
and Coody (11) who found Chlamydia trachomatis most prevalent. In other studies, Haemophilus
influenzae, Streptococcus pneumoniae and Pseudomonas aeruginosa were at
one point or the other found as the prevalent bacterial pathogens in ophthalmia
neonatorum.(19-21)
The difference in the number
of bacterial isolates from neonates with and without the disease in University of Benin
Teaching hospital was statistically significant (p=0.02). The larger number of isolates
from neonates with the disease shows the degree of pathogenicity of the organisms
implicated in ophthalmia neonatorum. In the past, the disease was thought to be caused by
either Neisseria gonorrhoeae or Chlamydia trachomatis.(35)
In all cases Neisseria
gonorrhoeae was isolated only from neonates with conjunctivitis in both hospitals. The
incidence of gonococcal ophthalmia neonatorum in Benin City within the period of study was
8.9 per 1,000 live births. This finding is close to the 15.5 in 1997 and 15.2 in1998 for
Aires, Argentina by De Bartolomeo et al.(9) An incidence of 1.7 per 10,000 live births was
reported in Florida, United States of America (8), which is very much lower than the
finding of this study. The incidence of gonococcal ophthalmia neonatorum appears high when
compared to those of advanced nations like United States of America and Canada, is still
within acceptable limits taking into cognizance the limited resources available for health
care delivery system in developing countries.
The campaign against
childhood blindness is gradually gaining grounds. In these days where there is an upsurge
of HIV/AIDS, many young adults who used to indulge in indiscriminate sex have refrained
themselves with a good percentage using precautionary measures like keeping a single
partner and the use of condoms. This has also helped in reducing the transmission of
sexually transmitted diseases hence the incidence of gonococcal ophthalmia neonatorum is
not alarming. Also, in the hospitals of study, preventive measures are taken as a drop of
1% silver nitrate solution is applied to each eye of the neonate some hours after birth.
Since gonococcal ophthalmia
neonatorum poses the greatest threat to a childs vision, it is generally believed
that the principal goal of ocular prophylaxis should be the prevention of the
disease.(15,36) The susceptibility of the organisms implicated to four antibiotics was
carried out. Staphylococcus aureus and Neisseria gonorrhoeae showed
susceptibility of 62.5 and 100% to erythromycin while 66.7% of Escherichia coli and
Klebsiella sp and 62.5% of Pseudomonas aeruginosa were susceptible to
gentamicin. Several studies have shown that erythromycin, tetracycline and silver nitrate
are effective in preventing gonococcal ophthalmia.(13,27,29,30) This study also shows that
erythromycin would help in the prevention of the disease when applied to the
neonates eyes some hours after birth.
The W.H.O. Vision
2020-"The Right to sight, Global initiative for the elimination of avoidable
blindness" is highly committed to the control of blindness in children. It has been
found that ophthalmia neonatorum among others are the major causes of blindness in
low-income countries in Africa and other continents.(37) In about 50% of children who are
blind today, the underlying cause could have been prevented, or the eye condition treated
to preserve vision or restore sight.(37)
- Kanski JJ. Clinical Ophthalmology.3rd
ed. Butterworth-Heinemann-Intl ed, Woburn, MA; 1998. p. 514.
- OHara, MA. Ophthalmia neonatorum. Pediatr
Clin North Am 1993;40(4):71525.
- Franson L, Klauss V. Neonatal
ophthalmia in developing countries (epidemiology, management and control). J Infect Dis
1986;11:18996.
- Kellos DS. Neisseria gonorrhoeae
virulence genetically united to clonal variation. J STD 1963;30:12749.
- Prescott LM, Harley JP, Klein DA.
Microbiology.4th ed. McGraw-Hills Co, U.S.A; 1999. p. 780.
- Pierce JM, Wada ME, Seal U. Ophthalmia
neonatorum in the 1980s (incidence, etiology and treatment). Br J Clin Med
1982;2:1623.
- Population and Public Health Branch.
Material Safety Data Sheet- Infectious substances. Health Canada 2001;14.
- Desenclos JC, Garrity D, Scaggs M, Wroten JE. Gonococcal infection of the newborn in Florida, 19841989. Sex Transm
Dis 1992;19(2):105110
- Di Bartolomeo S, Mirta DH, Janer M
et al. Incidence of Chlamydia trachomitis and other potential pathogens in neonatal
conjunctivitis. Int J Infect Dis 2001;5(3):13943.
- Isenberg SJ, Apt L, Wood M. The
influence of perinatal infective factors on ophthalmia neonatorum. J Pediatr Ophthalmol
Strabismus 1996;33(3):185-8.
- Yetman R, Coody D. Conjunctivitis: A
practice guideline. J Pediatric Health Care 1997;11(5):23844.
- Hammerschlag M. Neonatal conjunctivitis. Paediatric
Annals 1993;22(6):346351.
- Zanoni D, Isenberg S, Apt L. A
comparison of silver nitrate with erythromycin for prophylaxis against ophthalmia
neonatorum. Clinical pediatrics 1992;31:29598.
- Gao YN. Bacterial condition of low genital
tract of pregnant women and neonatal infection. Chung Hua Fu Chan Ko Tsa Chih
1993;28(12)7179, 759.
- Goldbloom RB. Prophylaxis for gonococcal
and chlamydial ophthalmia neonatorum . In: Canadian Task Force on the Periodic Health
Examination. Canadian Guide to Clinical Preventive Health Care. Ottawa: Health Canada
1994;16875.
- Lehman SS. An uncommon cause of ophthalmia
neonatorum: Neisseria Meningitides. J AAPOS 1999;3(5):316.
- Nsanze H, Dawodu A, Usmani A et al.
Ophthalmia neonatorum in United Arab Emirates. Ann Trop Paediatr 1996;16(1):2732.
- Ibhanesabhor SE, Otobo ES. In vitro
activity of human milk against the Causative organisms of ophthalmia neonatorum in Benin
City, Nigeria. J Trop Pediatr 1996;42(6):3279.
- Mani AR, Vidya KC. A microbiological
study of ophthalmia neonatorum in hospital-born babies. J Indian Med Assoc 1997;95(7):4167,
421.
- Schaller U, Mino de Kaspar H, Schriever S
et al. Ophthalmia neonatorum caused by Chlamydia trachomatis. Rapid diagnosis and
therapy. Ophthalmologie 1997;94(5):31720.
- Ramsey KH, Pousen CE, Motiu PP. The in
vitro antimicrobial capacity of human colostrums against Chlamydia trachomatis. J
Reprod Immunol 1998;38(2):15567.
- Coulaud JP. Sexually transmitted diseases
and mother-infant transmission (epidemiology and prevention). Bull Soc Pathol Exot 1991;84:43640.
- de Toledo AR, Chandler JW.
Conjunctivitis of the newborn. Infect Dis Clin North Am 1992;6(4):80713.
- Hoosen AA, Kharsany AB, Ison CA.
Single low-dose ceftriaxone for the treatment of gonococcal ophthalmia-implications for
the national programme for the syndromic management of sexually transmitted diseases. S
Afri Med J 2002;92(3):23840.
- Whitcher J. Neonatal ophthalmia: Have we
advanced in the last 20 years? Intl Ophthalmol Clin 1990;30(1):3944.
- Dunn PM. Dr Carl Crede (1819 1892)
and the prevention of ophthalmia neonatorum. Arch Dis Child Fetal Neonatal Ed
2000;83(2):F1589.
- Laga M, Plummer F, Piot P et al.
Prophylaxis of gonococcal and chlamydia ophthalmia neonatorum. New Engl J Med 1988;318(11):653-657.
- Laga, M, Meheus, A, Piot P.
Epidemiology and Control of gonococcal ophthalmia neonatorum. Bull World Health Organ 1989;67:4717.
- Isenberg S, Apt L, Wood M. The
controlled trial of povidone-iodine as prophylaxis against ophthalmia neonatorum. New
Engl J Med 1995; 332(9):562- 566.
- Bell T, Grayston T, Krohn M et al. Randomised trial of silver nitrate, erythromycin and no eye prophylaxis for the prevention
of conjunctivitis among newborns not at risk for gonococcal ophthalmitis. Pediatrics
1993;92(6):755-760.
- Hammerschlag M, Cummings C, Roblin PM et
al. Efficacy of neonatal ocular prophylaxis for the prevention of chlamydial and
gonococcal conjunctivitis. New Engl J Med 1989;320:769772.
- Isenberg SJ, Apt L, Yashimori R et al. Povidone-Iodine for ophthalmia neonatorum prophylaxis. Am J Ophthalmol 1994;118(6):7016.
- Kramer A, Below H, Behrens-Baumann W et
al. New Aspects of the Tolerance of the Antiseptic povidone-Iodine in Different ex vivo
Models. Dermatology 2002;204 suppl1:86-91.
- van Bogaert LJ. Ophthalmia neonatorum
revisited. Afr J Reprod Health 1998; 2(1):81-6.
- WHO meeting on prevention of childhood
blindness. World Health Organisation,1992.
- Canadian Task Force on the Periodic Health
Examination: The periodic health examination, 1992, update: 4. Prophylaxis for gonococcal
and chlamydial ophthalmia neonatorum. Can Med Assoc J 1992;147:144954.
- Gilbert C, Foster A. Childhood
blindness in the context of VISION 2020- the right to sight. Bull World Health Organ
2001;79(3):22732.
|